As the President and Managing Partner of Global Recruiters of Albuquerque (GRN), Bret Hendzel leverages over 25 years of senior management and C-level experience in the Life Sciences sector to excel in the realm of global executive recruiting. His extensive background in pharmaceutical, biopharma, biotech,...
As the President and Managing Partner of Global Recruiters of Albuquerque (GRN), Bret Hendzel leverages over 25 years of senior management and C-level experience in the Life Sciences sector to excel in the realm of global executive recruiting. His extensive background in pharmaceutical, biopharma, biotech, and bioinformatics allows him to understand the nuanced demands of these industries, enabling him to identify and place top-performing talent that aligns with the strategic goals of client organizations. Under Bret's leadership, GRN has cultivated a reputation for developing long-term strategic partnerships, ensuring that both client companies and candidates benefit from a collaborative and transparent recruitment process.
Bret's expertise extends to navigating the complexities of FDA regulations and Good Laboratory Practices (GLP), which are critical in the Life Sciences field. His deep understanding of R&D processes and biochemistry empowers him to assess candidates not just for their technical skills, but also for their potential to drive innovation and lead teams effectively. Key projects under his direction have included high-stakes searches for executive roles in emerging biotech firms and established pharmaceutical giants, where he has successfully placed leaders who have gone on to make significant contributions to their organizations.
Bret's commitment to honesty, integrity, and confidentiality is reflected in GRN's guiding principles, ensuring that every placement is not only a match of skills but also a fit for the company culture. By fostering a robust network within the Life Sciences community, Bret continues to enhance GRN's ability to deliver world-class permanent placement services, even under the most demanding deadlines. His leadership not only shapes the future of GRN but also contributes to the advancement of the Life Sciences industry as a whole.
